Showing results (11-20 of 51) with videos related to
Sort By:
Pageof 6
Circulation. Heart Failure|February 4, 2026
Prognostic Implications of Mitral Regurgitation Across Hypertrophic Cardiomyopathy Subtypes: A Report From REVEAL-HCM StudyYuki Obayashi, Takao Kato, Hiroki Shiomi, et al.European Heart Journal. Cardiovascular Pharmacotherapy|January 29, 2024
Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trialYuki Obayashi, Masahiro Natsuaki, Hirotoshi Watanabe, et al.Circulation Reports|June 11, 2025
An Aspirin-Free Strategy for Patients Undergoing Staged Percutaneous Coronary Intervention - A Subgroup Analysis of the STOPDAPT-3 TrialKo Yamamoto, Masahiro Natsuaki, Hirotoshi Watanabe, et al.JACC. Cardiovascular Interventions|June 5, 2025
Aspirin vs Clopidogrel 1 Month After Acute Coronary Syndrome With High-Bleeding Risk or ST-Segment ElevationYuki Obayashi, Masahiro Natsuaki, Hirotoshi Watanabe, et al.JACC. Cardiovascular Interventions|May 15, 2024
An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary InterventionKo Yamamoto, Masahiro Natsuaki, Hirotoshi Watanabe, et al.Journal of the American Heart Association|September 17, 2021
Newly Diagnosed Atrial Fibrillation in Acute Myocardial InfarctionYuki Obayashi, Hiroki Shiomi, Takeshi Morimoto, et al.Circulation. Cardiovascular Interventions|May 14, 2025
Aspirin-Free Strategy for PCI in Patients With High Bleeding Risk With or Without Acute Coronary Syndrome: A Subgroup Analysis From the STOPDAPT-3 TrialTetsuya Ishikawa, Masahiro Natsuaki, Hirotoshi Watanabe, et al.Journal of the American Heart Association|July 26, 2024
Aspirin-Free Strategy for Percutaneous Coronary Intervention in Patients With Oral Anticoagulation: Prespecified Subgroup Analysis From the STOPDAPT-3 TrialMasahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|December 8, 2022
Prevalence and Effects of High-Intensity Statins for Japanese Patients Presenting With Acute Coronary Syndrome - A Post Hoc Secondary Analysis of STOPDAPT-2 ACSHirotoshi Watanabe, Takeshi Morimoto, Ko Yamamoto, et al.JACC. Asia|November 27, 2025
Effect of Proton Pump Inhibitors in Patients Undergoing Percutaneous Coronary Intervention With Aspirin-Free StrategyTenjin Nishikura, Ko Yamamoto, Kohei Wakabayashi, et al.Pageof 6